Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Searching for potential therapeutics against chloroquine retinopathy through high-throughput drug screening (HTS)
Author Affiliations & Notes
  • Hyun Jee Kim
    Ophthalmology, Asan Medical Center Asan Institute for Life Sciences, Seoul, Korea (the Republic of)
    Ophthalmology, AMIST, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea (the Republic of)
  • Jeong A Choi
    Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea (the Republic of)
  • Jae-Young Koh
    Ophthalmology, Asan Medical Center, Seoul, Korea (the Republic of)
    Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea (the Republic of)
  • Joo-Young Lee
    Ophthalmology, Asan Medical Center, Seoul, Korea (the Republic of)
    Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea (the Republic of)
  • Young Hee Yoon
    Ophthalmology, Asan Medical Center, Seoul, Korea (the Republic of)
    Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Hyun Jee Kim None; Jeong A Choi None; Jae-Young Koh None; Joo-Young Lee None; Young Hee Yoon None
  • Footnotes
    Support  NRF-2017R1D1A1B05028221 / KHIDI and KDRC - HU20C0206
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3937. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hyun Jee Kim, Jeong A Choi, Jae-Young Koh, Joo-Young Lee, Young Hee Yoon; Searching for potential therapeutics against chloroquine retinopathy through high-throughput drug screening (HTS). Invest. Ophthalmol. Vis. Sci. 2024;65(7):3937.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : We previously showed that chloroquine (CQ)-induced retinal toxicity occurs mainly by the inhibition of autophagic flux. To find potential therapeutics against CQ toxicity we used ARPE-19 cells and measured cell death as well as marker for autophagic flux.

Methods : We selected potential therapeutic drugs against CQ-cytotoxicity in ARPE-19 cell cultures by screening the LOPAC®1280 (the library of pharmacologically active compounds, Sigma). Cell death was quantitatively assessed by measuring lactate dehydrogenase (LDH) activity released into the culture medium. In parallel, cell viability was also assessed using a 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay. For western blots for autophagy-related markers, cultured ARPE-19 cells were treated with 50 mM CQ for 3 hours. Lysosomal pH was measured by confocal microscopy using a lysosome pH indicator, Lysosensor DND-189.

Results : ARPE-19 cells developed cytosolic vacuoles within 1 hour after the onset of CQ-treatment. Twenty-four hours later, ARPE-19 cells showed a significant increase of CQ-induced cell death (84.42 ± 3.48 % by LDH assay) compared to non-treated control ARPE-19 cells. For the HTS, 10 mM of each compound from LOPAC®1280 library was added with CQ, and cell death was assessed 24 hours later. Initially, we selected 7 compounds that reduced CQ toxicity by 40% or more by LDH assay. Then, we tested concentration-protection effects of each with the MTT viability assay, and selected 3 compounds as candidates. Western blot analysis showed that LC3-II and p62 accumulated in ARPE-19 cells 3 hours after CQ treatment, likely as results of autophagy arrest. All 3 compounds reduced CQ-induced increases in p62 levels consistent with increases in autophagy flux. Lysosensor (DND-189) confocal microscopy showed that 3 compounds ameliorated CQ-induced alkaline shift of lysosomal lumens.

Conclusions : CQ induces lysosomal alkalinization, arrested autophagy, and death in ARPE-19 cells. The selected compounds reduced CQ-induced cell death likely via reacidifying lysosomes and consequently enhancing autophagy flux.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×